Member Info for Wisheyedbortum

Excellent post PP and that's what most reasonable people think in this country at the moment. Lemonaider you are also right in stating that Avacta has failed to make any money to date, but I have visited the company and met with Alastair Smith and believe me when I say that He is a seriously clever guy and a shrewd businessman and I still maintain that in 2014 you could easily double or triple your money, you just need a bit more patience. I've been here since 2009 and fully confident that I will be rewarded for sticking with Avacta.

...Dr. Matt Johnson, this should move the Affimer development along apace!

From my point of view, the slight movement in the sp has been triggered by selling activity and nothing else really. I have decided to wait for the Interims and trading update to make the bulk of my movements from trading account to ISAs. If you chech out the Avacta web site and go to interim results 2013 and trading update you will gain a good insight into where the Group is going and projected revenues. As far as Director dealings go, Alastair Smith stands to make £1,69 million for every 1p rise in the sp, so I don't think that He needs any more shares and probably the other Directors won't do too badly either. If you want to catch the very beginning of the Avacta share price rise, you should probably be investing early 2014. Not great, but I hope this helps.

..what I would have expected. Sensipod has completed the soak test successfully so the launch will be soon. It's worth remembering that nothing leaves Avacta unless it is 100%, hence the long delay, and when you see how intricate the Sensipod test cartridges are, it's understandable why the injection moulding presented such problems and why they have to be perfect.

Thanks for your reply. There's been some talk on iii regarding a T/O, but personally I can't see it.

Yea, fanks bb.

I don't believe that I have made such an awful grammatical error. IP Group is an investment company, I don't believe that IT buys companies, IT buys shares...... Shame on me!

IP Group is an investment company, I don't believe that they buy companies, they buy shares in the expectation like any other investor that the shares will rise in value. if the IP Group wanted to take over Avacta, why did it not take all of the new issue rather than holding back to allow two new investment houses in on the act? (one of them being NFU Mutual, I forget the other one). No one would buy a company that was commercially unproven and besides, Avacta more or less revolves around one person at the moment, which would not make good business sense to the IP Group Board. Excuse my ignorance, but what is wrt code 9......?

I'm not so sure that the bottom drawer is the place for AVCT shares. The recent placing was to accelerate the commercialization of mainly the Affimers, which will now bring forward the progress of this product and probably the predictions of Avacta's growth. I think that there will be a rise in the sp with the announcement of the launch of Sensipod, but the October interims will be most interesting. Will the Market concentrate on the losses or on the progress and future? I am building a holding in my ISA, but I will sell my trading account holding after the Sensipod announcement and buy into the ISA before October, hoping to get the best price all round. I think that bb and PP hold good solid views here and it's good to see our long term faith in Avacta starting to come good. It is true that our money could have been working harder elsewhere, but medium term the rewards I believe will be very good indeed, and long term? who knows.

As per usual, I could be wrong here, but I think that it is 30% of the shares in public hands. Around 48% is still owned by the company/directors. Dr. Smith said that He still had control of the company. I've never had a Singapore Sling, I prefer a Rusty Nail.

Yes I did and I haven't really had the time to write a report, but here are my thoughts. Dr. Alastair Smith, very clever man, shrewd businessman and a very nice Guy. Took us through the products, the technology and the market places for them. We then toured the premises (two buildings) and saw Optim production, AX-1 Sensipod production, labs, Affimer production and storage along with the affimer array printing machine. We returned to the boardroom to discuss future markets for Avacta and to take a look at the cartridges for Optim and Sensipod. I've also since read an investment report about Avacta not normally available to PIs. So what do I think? Alastair Smith is building a gem of a company here. Long term, Sensipod and Affimers will be the main earners for the company with Optim acting as the initial booster rockets. At the moment, there is a batch of Sensipods on soak test and if everything goes according to plan the launch will take place within the next week or so. Optim is back in full production ie 22 units per year rising to 44 units pa within 3 years. At present there are over 40 units in the field with 125 validated sales enquiries pending. The Affimers will be sold via Antibody distributors worldwide and they will go to the largely unregulated R&D businesses. There are many variables that may affect the future of Avacta so predicting the future share price would be extremely difficult, however 1.7p next year and 10p 3-5years has been suggested. From my point of view and barring a T/O, I see this as a very good 5 year investment if things go according to plan and after that, it could be an extraordinary one. I am sorry to be vague, but the amount of info to assimilate from the visit may take some while, especially when you are knocking on a bit.

You are most welcome. It's a pity that you call yourself thick, which I doubt you are because if you've ever dealt with "thick" people, they actually don't realize that they are thick and you wouldn't be on here if you were.

August 6th AIM shares can go into ISAs and if you go to the Avacta Group website, click on "RNS and Documents" then "Preliminary announcement 2013" then scroll down to "Avacta's market opportunity" it shows you a management forecast of each division's potential turnover and the timescale in years. Of course, £125m doesn't account for the increase in revenue that may occur in Biopharmaceuticals and Animal Health over the five year period.

And yet, when you consider that revenues in five year's time are projected to be £125 million for Avacta, the reaction to today's news by the market shows that you only have a relatively short time to pick up these shares at this very low price. Roll on August 6th!

Good news this morning about ForteBio. It won't do much for the sp but the "good growth in the sales pipeline for Optim 2" may well do soon.

but I'll confirm my destination nearer the time, I'm assuming it's Thorpe Arch estate, Wetherby.

..I was an expert, but unfortunately I am not, thanks anyway. However, I am due to visit Avacta very shortly to gain the necessary information I need to make a serious decision regarding my future investments. Bearing in mind the fact that from August 6th, AIMs can go into ISAs, I believe that Avacta is a one off opportunity to provide a tax free income for a very long time. I may be completely wrong, but if I can confirm my beliefs about the future of Avacta, I think it's worth taking the gamble. If I am allowed to, I will post my thoughts on this board.

I think that we are quietly confident on this board, but the share price is still way down on what it was, so nothing to get excited about at present. The placing will accelerate the commercialization of all products so the buzz is beginning.

Some good points there.

I believe that AX-1 is now being actively sold although there is no news on quantities. What I find rather strange is that the sp has been hammered for quite a while now and on no news. Many buys are going through as sells, brokers have it as a strong buy and I have it on good authority that the sp in no way reflects the company's present situation and that a statement is due soon that will bring the market up to date. So why the drop in the sp? I'm looking on the positive side and thinking that a considerable rise in the sp is on the cards. Anybody any thoughts?